![Choosing between available adalimumab products – SPS - Specialist Pharmacy Service – The first stop for professional medicines advice Choosing between available adalimumab products – SPS - Specialist Pharmacy Service – The first stop for professional medicines advice](https://www.sps.nhs.uk/wp-content/uploads/2023/02/Humira-40mg-PFS-and-Carton.png)
Choosing between available adalimumab products – SPS - Specialist Pharmacy Service – The first stop for professional medicines advice
![Natalia on X: "1/2 Anyone else with #crohns #eczema struggling with safety syringes? I injected #humira for 10yr, great control but since changing to #stelara & #dupilumab have to wrestle with big, Natalia on X: "1/2 Anyone else with #crohns #eczema struggling with safety syringes? I injected #humira for 10yr, great control but since changing to #stelara & #dupilumab have to wrestle with big,](https://pbs.twimg.com/media/FLa45NQWUAQ0ZCv.jpg)
Natalia on X: "1/2 Anyone else with #crohns #eczema struggling with safety syringes? I injected #humira for 10yr, great control but since changing to #stelara & #dupilumab have to wrestle with big,
INSTRUCTIONS FOR USE HUMIRA® (Hu-MARE-ah) (adalimumab) 40 MG/0.8 ML, 20 MG/0.4 ML AND 10 MG/0.2 ML SINGLE-USE PREFILLED SYRINGE
INSTRUCTIONS FOR USE HUMIRA® (Hu-MARE-ah) (adalimumab) 40 MG/0.8 ML, 20 MG/0.4 ML AND 10 MG/0.2 ML SINGLE-USE PREFILLED SYRINGE
INSTRUCTIONS FOR USE HUMIRA® (Hu-MARE-ah) (adalimumab) 40 MG/0.8 ML, 20 MG/0.4 ML AND 10 MG/0.2 ML SINGLE-USE PREFILLED SYRINGE
INSTRUCTIONS FOR USE HUMIRA® (Hu-MARE-ah) (adalimumab) 40 MG/0.8 ML, 20 MG/0.4 ML AND 10 MG/0.2 ML SINGLE-USE PREFILLED SYRINGE
![AbbVie and Eisai Announce the Launch of HUMIRA® Pen, an Auto-InjectorFormulation for Fully Human Anti-TNF-α Monoclonal Antibody HUMIRA® | Investors(2018) | EA Pharma Co., Ltd. AbbVie and Eisai Announce the Launch of HUMIRA® Pen, an Auto-InjectorFormulation for Fully Human Anti-TNF-α Monoclonal Antibody HUMIRA® | Investors(2018) | EA Pharma Co., Ltd.](https://www.eapharma.co.jp/sites/default/files/corporate_files/en_news/2018/images/0611.png)